iOmx Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- iOmx Therapeutics's estimated annual revenue is currently $17.1M per year.
- iOmx Therapeutics's estimated revenue per employee is $201,000
Employee Data
- iOmx Therapeutics has 85 Employees.
- iOmx Therapeutics grew their employee count by 23% last year.
iOmx Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Group Leader (Associate Director) Preclinical Pharmacology and Biomarker Development | Reveal Email/Phone |
3 | Director Project & Portfoliomanagement | Reveal Email/Phone |
4 | Director Business Development | Reveal Email/Phone |
5 | Senior Manager IT & Operations | Reveal Email/Phone |
6 | Senior Scientist | Reveal Email/Phone |
7 | Biomarker Development Lead | Reveal Email/Phone |
8 | Group Leader In vitro Pharmacology and Biomarker | Reveal Email/Phone |
9 | Principal Research Associate | Reveal Email/Phone |
10 | Principal Research Associate | Reveal Email/Phone |
iOmx Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is iOmx Therapeutics?
iOmx is a new-age start-up biotech company in the immuno-oncology field. We are focused on innovation-driven research to advance our proprietary early stage novel immune-checkpoint molecules through pre-clinical and clinical development. Follow this page to keep yourself updated about our journey as we advance in creating next-generation immunotherapy treatments for cancer patients. Imprint: https://iomx.com/imprint
keywords:N/A
N/A
Total Funding
85
Number of Employees
$17.1M
Revenue (est)
23%
Employee Growth %
N/A
Valuation
N/A
Accelerator
iOmx Therapeutics News
While targeted therapeutics have recently emerged as alternatives to harsh ... and iOmx, and works closely with academic founder Dr. Jeker.
MARTINSRIED / MUNICH, Germany, April 07, 2022 (GLOBE NEWSWIRE) -- iOmx Therapeutics AG (iOmx), a biopharmaceutical company developing cancer...